Clinical trials are needed to find new medicines for the patients that need them.
Clinical Trials are conducted in several steps, called phases.
If you would like to learn more about clinical trials we provide you with answers to frequently asked questions.
At Bayer, we know there is strength in diversity - a value which is reflected in our commitment to our employees and the population we serve. Through our vision of "Health for all, hunger for none," we are committed to the goal of inclusive clinical trials that represent the diversity required to address the needs of all patients. To accomplish this, we are working with clinicians, research scientists, vendors, health authorities, ethics committees, and partners in patient engagement to ensure that our purpose of "Science for a Better Life" touches every life, regardless of race, ethnicity, sex/gender, age, or any other characteristic that may present a barrier to clinical trial participation.
As the participant, you are at the heart of any clinical study and your rights are our top priority. We want to make sure you know what to expect before and during the trial, learn and understand what happens after the trial concludes, and know what to expect from our commitments to disclosure and publishing of clinical trial results.
If you want to learn more about benefits and risks of medicines, the Bayer's Patient Knowledge Tour page provides you with some useful information on the benefits and risks of drugs and how they are researched, developed, and continuously monitored and evaluated for safety.
Bayer is fully committed to make information about its planned and ongoing clinical trials publically available. This is done in line with the position of the global pharmaceutical industry associations and related laws. Bayer will also make results of trials in patients public and provide free access to this information on the internet, irrespective of whether the results of a trial for one of our products are positive or negative.
Bayer is committed to sharing of study patient data with qualified researchers as a transparency measure to advance medical knowledge and public health and foster scientific discovery. Data sharing is following international standards to protect patient’s data privacy.
Bayer provides free access to study plans and to results of clinical studies on several publically accessible Clinical Trial Registries on the internet.
To access information on Bayer Trials, please visit the Bayer Clinical Trials Explorer page. To read the complete Bayer Clinical Trial Transparency Policy, please click “read more” below.
Copyright © Bayer
Powered by
The Bayer Clinical Trials Registry and Results Database website contains information on clinical trials sponsored by Bayer, and is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research.
The information contained within the website is not intended to replace the advice of a healthcare professional and should not be considered as a recommendation. Patients should always seek medical advice before making any decisions on their treatment. Healthcare professionals should always refer to the specific labeling information approved for the patient's country or region. The data on the website should not be considered as prescribing advice.
The data on the website may differ from published or presented data and are a reflection of the limited information provided there. The results from a single trial need to be considered in the context of the full clinical research for a drug.
All reasonable precautions have been taken to ensure the accuracy, security and confidentiality of the information available through the site. Bayer may amend the information at any time without notice.